(Q38649606)

5 September 2017

Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies (English)

1 reference

5 September 2017

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Luca Piccoli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Nicky Dunn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Malin Ryner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ali Manouchehrinia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Katharina Fink

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Fredrik Piehl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Anna Fogdell-Hahn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 July 2017

1 reference

Multiple Sclerosis Journal

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1224-1233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

The Swedish MS registry – clinical support tool and scientific resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458517720044

21 January 2018

Identifiers

DOI

10.1177/1352458517720044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28762877%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference